Polyplex Past Earnings Performance
Past criteria checks 4/6
Polyplex's earnings have been declining at an average annual rate of -17.3%, while the Chemicals industry saw earnings growing at 14.3% annually. Revenues have been growing at an average rate of 9.9% per year. Polyplex's return on equity is 5%, and it has net margins of 2.3%.
Key information
-17.3%
Earnings growth rate
-17.0%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | 9.9% |
| Return on equity | 5.0% |
| Net Margin | 2.3% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Polyplex makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 65,987 | 1,544 | 6,342 | 0 |
| 30 Jun 24 | 64,320 | 945 | 6,007 | 0 |
| 31 Mar 24 | 63,069 | 378 | 6,088 | 0 |
| 31 Dec 23 | 62,952 | 370 | 5,645 | 0 |
| 30 Sep 23 | 66,630 | 711 | 5,438 | 0 |
| 30 Jun 23 | 71,802 | 1,582 | 4,996 | 0 |
| 31 Mar 23 | 76,523 | 3,484 | 5,078 | 0 |
| 31 Dec 22 | 78,711 | 5,265 | 4,889 | 0 |
| 30 Sep 22 | 77,587 | 6,633 | 4,861 | 0 |
| 30 Jun 22 | 72,170 | 6,443 | 4,813 | 0 |
| 31 Mar 22 | 66,244 | 5,688 | 4,980 | 0 |
| 31 Dec 21 | 60,327 | 5,083 | 4,751 | 0 |
| 30 Sep 21 | 55,189 | 4,642 | 4,691 | 0 |
| 30 Jun 21 | 51,986 | 4,447 | 4,412 | 0 |
| 31 Mar 21 | 49,183 | 5,118 | 4,386 | 0 |
| 31 Dec 20 | 48,140 | 4,095 | 4,446 | 0 |
| 30 Sep 20 | 46,685 | 3,491 | 4,346 | 0 |
| 30 Jun 20 | 45,296 | 3,797 | 4,177 | 0 |
| 31 Mar 20 | 44,871 | 2,820 | 3,995 | 0 |
| 31 Dec 19 | 44,589 | 3,610 | 3,818 | 0 |
| 30 Sep 19 | 45,369 | 3,672 | 3,696 | 0 |
| 30 Jun 19 | 46,219 | 3,501 | 3,660 | 0 |
| 31 Mar 19 | 45,699 | 3,300 | 3,544 | 0 |
| 31 Dec 18 | 43,879 | 2,867 | 3,455 | 0 |
| 30 Sep 18 | 41,316 | 2,597 | 3,316 | 0 |
| 30 Jun 18 | 38,217 | 2,055 | 3,118 | 0 |
| 31 Mar 18 | 35,723 | 1,595 | 3,115 | 0 |
| 31 Dec 17 | 34,230 | 1,367 | 2,993 | 0 |
| 30 Sep 17 | 33,003 | 1,596 | 2,994 | 0 |
| 30 Jun 17 | 32,351 | 1,877 | 2,919 | 0 |
| 31 Mar 17 | 32,010 | 2,317 | 3,014 | 0 |
| 31 Dec 16 | 31,943 | 2,484 | 3,054 | 0 |
| 30 Sep 16 | 31,612 | 1,712 | 3,035 | 0 |
| 30 Jun 16 | 31,628 | 908 | 2,945 | 0 |
| 31 Mar 16 | 32,021 | 290 | 3,036 | 0 |
| 31 Dec 15 | 31,173 | -157 | 5,873 | 0 |
| 30 Sep 15 | 31,404 | -296 | 5,814 | 0 |
| 30 Jun 15 | 31,499 | -18 | 2,758 | 0 |
| 31 Mar 15 | 32,042 | 379 | 2,753 | 0 |
| 31 Dec 14 | 32,703 | 155 | 5,380 | 0 |
| 30 Sep 14 | 33,101 | 78 | 5,356 | 0 |
| 30 Jun 14 | 33,335 | 213 | 2,561 | 0 |
| 31 Mar 14 | 31,722 | -68 | 5,198 | 0 |
| 31 Dec 13 | 29,784 | -400 | 4,837 | 0 |
Quality Earnings: 524051 has high quality earnings.
Growing Profit Margin: 524051's current net profit margins (2.3%) are higher than last year (1.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 524051's earnings have declined by 17.3% per year over the past 5 years.
Accelerating Growth: 524051's earnings growth over the past year (117.1%) exceeds its 5-year average (-17.3% per year).
Earnings vs Industry: 524051 earnings growth over the past year (117.1%) exceeded the Chemicals industry 8%.
Return on Equity
High ROE: 524051's Return on Equity (5%) is considered low.